A detailed history of Twin Lakes Capital Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Twin Lakes Capital Management, LLC holds 6,862 shares of ABT stock, worth $771,288. This represents 0.49% of its overall portfolio holdings.

Number of Shares
6,862
Previous 6,892 0.44%
Holding current value
$771,288
Previous $783,000 8.94%
% of portfolio
0.49%
Previous 0.54%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$100.73 - $112.44 $3,021 - $3,373
-30 Reduced 0.44%
6,862 $713,000
Q1 2024

May 10, 2024

BUY
$109.52 - $120.96 $2,190 - $2,419
20 Added 0.29%
6,892 $783,000
Q4 2023

Feb 08, 2024

SELL
$90.19 - $110.4 $5,772 - $7,065
-64 Reduced 0.92%
6,872 $756,000
Q3 2023

Nov 16, 2023

BUY
$95.53 - $114.62 $1,624 - $1,948
17 Added 0.25%
6,936 $671,000
Q2 2023

Aug 08, 2023

BUY
$100.78 - $112.29 $1,209 - $1,347
12 Added 0.17%
6,919 $754,000
Q1 2023

May 09, 2023

SELL
$96.86 - $114.01 $290 - $342
-3 Reduced 0.04%
6,907 $699,000
Q4 2022

Feb 03, 2023

BUY
$95.06 - $111.52 $1,520 - $1,784
16 Added 0.23%
6,910 $758,000
Q3 2022

Oct 21, 2022

BUY
$96.76 - $112.03 $1,838 - $2,128
19 Added 0.28%
6,894 $667,000
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $25,721 - $31,089
-252 Reduced 3.54%
6,875 $747,000
Q1 2022

May 12, 2022

SELL
$114.02 - $139.04 $31,469 - $38,375
-276 Reduced 3.73%
7,127 $844,000
Q4 2021

Feb 07, 2022

SELL
$115.53 - $141.46 $1,039 - $1,273
-9 Reduced 0.12%
7,403 $1.04 Million
Q3 2021

Nov 01, 2021

BUY
$116.66 - $129.06 $211,271 - $233,727
1,811 Added 32.33%
7,412 $876,000
Q2 2021

Aug 06, 2021

SELL
$105.79 - $124.53 $36,391 - $42,838
-344 Reduced 5.79%
5,601 $649,000
Q1 2021

May 18, 2021

SELL
$108.84 - $128.23 $5,986 - $7,052
-55 Reduced 0.92%
5,945 $712,000
Q4 2020

Feb 26, 2021

BUY
$105.0 - $114.42 $630,000 - $686,520
6,000 New
6,000 $657,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Twin Lakes Capital Management, LLC Portfolio

Follow Twin Lakes Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Lakes Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Twin Lakes Capital Management, LLC with notifications on news.